Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVTX | AKBA | USNA | ||
| Company | Avalo Therapeutics Inc | Akebia Therapeutics | Usana Health Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 13.80 | 1.3700 | 17.06 | ||
| High | 14.02 | 1.3800 | 17.18 | ||
| Low | 13.49 | 1.3200 | 16.76 | ||
| Latest | 13.89 | 1.3400 | 16.92 | ||
| Change | -0.06 | -0.0500 | -0.36 | ||
| % Change | -0.43% | -3.60% | -2.08% | ||
| Volume | 559,100 | 2,635,200 | 141,200 | ||
| 20-Day Average Volume | 812,360 | 2,880,065 | 155,790 | ||
| Previous Close | 13.95 | 1.3900 | 17.28 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.82 | 1.3670 | 17.73 | ||
| 20-Day Raw Stochastic | 13.57% | 42.11% | 4.63% | ||
| 20-Day Relative Strength | 41.01 | 46.80 | 36.28 | ||
| Weighted Alpha | +56.46 | -43.31 | -40.38 | ||
| Today's Opinion | 8% Sell | 72% Sell | 88% Sell | ||
| Previous Opinion | 8% Sell | 40% Sell | 88% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.50% since 03/20/26 | -5.63% since 03/20/26 | +0.06% since 03/20/26 | ||
| Low | 13.07 on 03/23/26 | 1.3200 on 03/27/26 | 16.76 on 03/27/26 | ||
| High | 14.79 on 03/25/26 | 1.4500 on 03/23/26 | 17.79 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | -20.63% since 02/27/26 | +2.29% since 02/27/26 | -21.38% since 02/27/26 | ||
| Low | 13.07 on 03/23/26 | 1.1800 on 03/05/26 | 16.72 on 03/09/26 | ||
| High | 19.08 on 03/04/26 | 1.5600 on 03/17/26 | 21.14 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -24.39% since 12/26/25 | -19.28% since 12/26/25 | -14.72% since 12/26/25 | ||
| Low | 13.04 on 02/05/26 | 1.1400 on 02/20/26 | 16.72 on 03/09/26 | ||
| High | 19.08 on 03/04/26 | 1.6600 on 12/29/25 | 22.90 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +28.61% since 09/26/25 | -51.09% since 09/26/25 | -40.69% since 09/26/25 | ||
| Low | 12.41 on 10/02/25 | 1.1400 on 02/20/26 | 16.72 on 03/09/26 | ||
| High | 20.72 on 12/11/25 | 3.2000 on 10/28/25 | 28.52 on 09/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 316,525 | 358,958 | 312,292 | ||
| Shares Outstanding, K | 22,788 | 267,879 | 18,457 | ||
| Annual Sales | 440,000 | 236,200,000 | 925,260,000 | ||
| Annual Net Income | -35,130,000 | -5,350,000 | 10,760,000 | ||
| Last Quarter Sales | 0 | 57,620,000 | 226,200,000 | ||
| Last Quarter Net Income | -30,630,000 | -12,240,000 | -1,780,000 | ||
| 60-Month Beta | 0.84 | 0.39 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 03/23/26 | -0.05 on 02/26/26 | 0.60 on 02/17/26 | ||
| Latest Earnings Date | 05/11/26 | 05/14/26 | 04/28/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 9.00 | ||